DE820303T1 - p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES - Google Patents

p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES

Info

Publication number
DE820303T1
DE820303T1 DE0820303T DE95944502T DE820303T1 DE 820303 T1 DE820303 T1 DE 820303T1 DE 0820303 T DE0820303 T DE 0820303T DE 95944502 T DE95944502 T DE 95944502T DE 820303 T1 DE820303 T1 DE 820303T1
Authority
DE
Germany
Prior art keywords
peptidanalog
compilation
diabetes
diagnosis
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0820303T
Other languages
English (en)
Inventor
Irun R Cohen
Dana Elias
Matityahu Fridkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE820303(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE820303T1 publication Critical patent/DE820303T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE0820303T 1994-12-21 1995-12-20 p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES Pending DE820303T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
PCT/US1995/016596 WO1996019236A1 (en) 1994-12-21 1995-12-20 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (1)

Publication Number Publication Date
DE820303T1 true DE820303T1 (de) 1999-05-20

Family

ID=26322965

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69531004T Expired - Lifetime DE69531004T2 (de) 1994-12-21 1995-12-20 p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE0820303T Pending DE820303T1 (de) 1994-12-21 1995-12-20 p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69531004T Expired - Lifetime DE69531004T2 (de) 1994-12-21 1995-12-20 p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES

Country Status (31)

Country Link
EP (1) EP0820303B1 (de)
JP (2) JP3420245B2 (de)
KR (1) KR100400480B1 (de)
CN (1) CN1233417C (de)
AR (1) AR002949A1 (de)
AT (1) ATE242005T1 (de)
AU (1) AU707835B2 (de)
BR (1) BR9510102A (de)
CA (1) CA2208274C (de)
CZ (1) CZ293784B6 (de)
DE (2) DE69531004T2 (de)
DK (1) DK0820303T3 (de)
ES (1) ES2201137T3 (de)
FI (1) FI118373B (de)
HR (1) HRP950612B1 (de)
HU (1) HU224160B1 (de)
IL (1) IL116499A0 (de)
IS (1) IS1966B (de)
MX (1) MX9704738A (de)
NO (1) NO317350B1 (de)
NZ (1) NZ301440A (de)
PL (1) PL184145B1 (de)
PT (1) PT820303E (de)
RO (1) RO116777B1 (de)
RS (1) RS49517B (de)
SI (1) SI0820303T1 (de)
TR (1) TR199501630A2 (de)
TW (1) TW496872B (de)
UA (1) UA42040C2 (de)
UY (1) UY24130A1 (de)
WO (1) WO1996019236A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
WO1997043649A1 (en) * 1996-05-14 1997-11-20 Winnacker Ernst Ludwig CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
WO2002016549A2 (en) * 2000-08-25 2002-02-28 Yeda Research And Development Co. Ltd. METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
ES2526822T3 (es) 2002-01-31 2015-01-15 Andromeda Bio Tech Ltd. Péptidos hsp y análogos para la modulación de respuestas inmunes mediante células presentadoras de antígeno
WO2005072056A2 (en) 2004-01-28 2005-08-11 Develogen Israel Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
US8691772B2 (en) 2005-01-04 2014-04-08 Yeda Research And Development Co. Ltd. HSP60, HSP60 peptides and T cell vaccines for immunomodulation
JP2008531730A (ja) * 2005-03-04 2008-08-14 キュアーディーエム、インク． Ｉ型真性糖尿病及び他の症状を治療するための方法及び薬学的組成物
EA013821B1 (ru) 2005-05-25 2010-08-30 Кьюрдм, Инк. Проостровковые пептиды человека, их производные и аналоги и способы их применения
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
WO2008064306A2 (en) 2006-11-22 2008-05-29 Curedm, Inc. Methods and compositions relating to islet cell neogenesis
SG185940A1 (en) 2007-08-30 2012-12-28 Curedm Group Holdings Llc Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
EP2819689A1 (de) 2012-03-01 2015-01-07 Yeda Research and Development Co. Ltd. Regenerierung von beta-inselzellen durch hsp60-derivierte peptide
CN104244967A (zh) 2012-03-01 2014-12-24 耶达研究与发展有限公司 用于抑制和治疗非自身免疫性糖尿病的Hsp60衍生肽和肽类似物
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
ES2201137T3 (es) 2004-03-16
DE69531004D1 (de) 2003-07-10
AR002949A1 (es) 1998-05-27
MX9704738A (es) 1997-10-31
JP3420245B2 (ja) 2003-06-23
AU707835B2 (en) 1999-07-22
CN1175214A (zh) 1998-03-04
DE69531004T2 (de) 2004-02-05
FI118373B (fi) 2007-10-31
NO972849L (no) 1997-08-13
CZ190897A3 (en) 1997-11-12
ATE242005T1 (de) 2003-06-15
EP0820303B1 (de) 2003-06-04
YU78795A (sh) 1998-05-15
HUT78092A (hu) 1999-09-28
CA2208274C (en) 2005-12-06
IS1966B (is) 2004-12-15
BR9510102A (pt) 1997-11-25
PL184145B1 (pl) 2002-09-30
JP3554319B2 (ja) 2004-08-18
UA42040C2 (uk) 2001-10-15
NO972849D0 (no) 1997-06-19
JP2004026797A (ja) 2004-01-29
IS4510A (is) 1997-06-19
RS49517B (sr) 2006-10-27
HRP950612A2 (en) 1997-10-31
CN1233417C (zh) 2005-12-28
SI0820303T1 (en) 2003-10-31
AU4686696A (en) 1996-07-10
UY24130A1 (es) 1996-06-11
EP0820303A1 (de) 1998-01-28
NZ301440A (en) 2000-01-28
KR100400480B1 (ko) 2003-12-31
PL321091A1 (en) 1997-11-24
FI972669A (fi) 1997-08-15
CA2208274A1 (en) 1996-06-27
IL116499A0 (en) 1996-03-31
HU224160B1 (hu) 2005-06-28
DK0820303T3 (da) 2003-10-06
EP0820303A4 (de) 1998-03-11
PT820303E (pt) 2003-10-31
TW496872B (en) 2002-08-01
HRP950612B1 (en) 2003-12-31
NO317350B1 (no) 2004-10-18
RO116777B1 (ro) 2001-06-29
TR199501630A2 (tr) 1996-07-21
WO1996019236A1 (en) 1996-06-27
CZ293784B6 (cs) 2004-07-14
FI972669A0 (fi) 1997-06-19
JPH10511649A (ja) 1998-11-10

Similar Documents

Publication Publication Date Title
DE820303T1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE69725339D1 (de) Vorrichtung zur diagnose und behandlung von arrhythmien
DE69942614D1 (de) Vorrichtung zur diagnose und therapie von elektrophysiologischen krankheiten
DE69631157D1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes
DE69720058D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69726195D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
DE69633835D1 (de) Als ampulle dienende spritze und spritze zur blutentnahme
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
DE58908452D1 (de) Medizinisches Gerät zur Diagnose und/oder Therapie.
DE68911975D1 (de) Ophthalmoskopisches Diagnoseverfahren und Gerät.
DE69009045T2 (de) Kapsel für medizinische Zwecke und Vorrichtung zu deren Aktivierung.
DE68920299T2 (de) Dichtung und diese verwendendes medizinisches Gerät.
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
DE59704432D1 (de) Vorrichtung zur endoskopischen Diagnose und Behandlung von Gewebe
DE69034218D1 (de) Impfstoff und Diagnostikum für den Schweine-Cholera-Virus
DE68905298T2 (de) Dichtung und diese verwendendes medizinisches geraet.
DE69813354T2 (de) Mittel zur Behandlung von Herzkrankheiten
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATA17197A (de) Einrichtung zur behandlung eines patienten
ATA38797A (de) Polymere-infusionslösung zur anwendung bei der diagnose von tumoren, gegebenenfalls zu deren behandlung
ATA51896A (de) Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
ATA17797A (de) Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen